This meta-analysis incorporated 18 studies of 10846 breast cancer cases and 11723 controls concerning the Arg399Gln in XRCC1. The Arg399Gln variant presented significant association breast cancer risk in the American population. This evidence concerns the gene XRCC1 and breast cancer.